Meatly raises £10.4M in Series A
Meatly, a London-based company focused on developing cultivated chicken meat, has secured £10.4 million ($13 million) in a Series A funding round. The round was spearheaded by Oyster Bay Venture Capital and included participation from Clean Growth Fund and JamJar Investments. This capital injection is expected to drive Meatly's efforts to scale its production processes and further its aim of providing an alternative to traditional poultry products.
The funding will allow Meatly to expand its laboratory facilities and accelerate the commercialization of its cell-cultivated meat products. By creating chicken meat from animal cells without slaughter, the company aligns itself with a growing movement towards sustainable and ethical food production. While exact terms of the investment were not disclosed, the inclusion of prominent investors suggests confidence in Meatly’s technology and strategic direction.
Meatly’s approach offers a potential solution to the increasing demand for protein while addressing environmental and ethical concerns associated with conventional meat production. The investment will enhance its ability to bring its cultivated chicken product to market, capitalizing on innovations in biotechnology to reduce reliance on livestock farming. Oyster Bay Venture Capital, having experience in backing early-stage sustainable food startups, appears to be leveraging its expertise to support the development of what it views as a transformative product.
This funding round reflects a broader trend in capital markets where investors seek opportunities in the burgeoning cultivated meat sector. As regulatory frameworks begin to accommodate cell-cultured products, companies like Meatly are gaining momentum, aiming to capture part of the traditional meat market share. Competitors in the cultivated meat industry are likely watching closely, as each successful funding round and technological breakthrough adds pressure to innovate swiftly.
Looking ahead, Meatly must navigate regulatory approvals necessary for market entry, a process that is crucial for its growth trajectory. As it moves forward with product development and regulatory engagements, milestones such as obtaining food safety certifications will be crucial. The successful scaling and commercialization of its products could set new standards for the industry and influence how cultivated meat is perceived globally.
Deal timeline
This transaction is classified in Cultivated Meat with a reported deal value of £10.4M. Figures and status may change as sources update.